Evaluating estrogen for Alzheimer disease poses ethical and logistical challenges.
Skolnick
A A
AA
D000544:Alzheimer Disease / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D032882:Comprehension; D004967:Estrogens / Q000627:therapeutic use*; D004992:Ethics, Medical; D005260:Female; D006801:Humans; D018579:Patient Selection; D017698:Postmenopause; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D013315:Stress, Psychological
D004967:Estrogens